کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
5555596 1559745 2017 6 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
The protective effect of dopamine on ventilator-induced lung injury via the inhibition of NLRP3 inflammasome
موضوعات مرتبط
علوم زیستی و بیوفناوری ایمنی شناسی و میکروب شناسی ایمونولوژی
پیش نمایش صفحه اول مقاله
The protective effect of dopamine on ventilator-induced lung injury via the inhibition of NLRP3 inflammasome
چکیده انگلیسی


- Dopamine (DA) attenuates VILI and inflammatory infiltration.
- DA reduces NLRP3 inflammasome production and protein expression in VILI.
- DA inhibits the production of interleukin (IL)-1β, IL-6, IL-18 and TNF-α in VILI.
- DA exerts protective effect by alleviating inflammation through inhibition of NLRP3.

Dopamine (DA), a neurotransmitter, was previously shown to have anti-inflammatory effects. However, its role in ventilator-induced lung injury (VILI) has not been explicitly demonstrated. This study aimed to investigate the therapeutic efficacy and molecular mechanisms of dopamine in VILI. Rats were treated with dopamine during mechanical ventilation. Afterwards, the influence of dopamine on histological changes, pulmonary edema, the lung wet/dry (W/D) ratio, myeloperoxidase (MPO) activity, polymorphonuclear(PMN)counts, inflammatory cytokine levels, and NLRP3 inflammasome protein expression were examined. Our results showed that dopamine significantly attenuated lung tissue injury, the lung W/D ratio, MPO activity and neutrophil infiltration. Moreover, it inhibited inflammatory cytokine levels in the Bronchoalveolar lavage fluid (BAL). In addition, dopamine significantly inhibited ventilation-induced NLRP3 activation. Our experimental findings demonstrate that dopamine exerted protective effects in VILI by alleviating the inflammatory response through inhibition of NLRP3 signaling pathways. The present study indicated that dopamine could be a potential effective therapeutic strategy for the treatment of VILI.

ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: International Immunopharmacology - Volume 45, April 2017, Pages 68-73
نویسندگان
, , , , , , , , , ,